| Preliminary Scientific Programme |
| SATURDAY | SUNDAY | MONDAY | TUESDAY | WEDNESDAY |
| Sunday, 11 June 2006 |
08.30 – 10.15 Room: Hall B Chairperson: The One Airway Link: An Update of Biology
& Physiology Management of Asthma Complicated by AR: New
Guidelines and Clinical Experience Pediatric Airway Inflammation: An Approach
to Management
Room: Hall C Chairpersons: Epidemiology of contact allergy Atopy as risk factor for contact dermatitis Avoiding epidemics of allergic contact dermatitis
to preservatives Pathomechanism of protein contacts dermatitis
Room: Hall E1 Chairpersons: Epidemiology in Europe Anaphylaxis in the community Triggers of Anaphylaxis Recommendation from the Task Force
1: How to Cope with Side Effects of Specific
Immunotherapy 2: Diagnosis of Autoimmunity 3: Practical Rhinology
Room: Hall F Chairpersons: The specialty in Europe The curriculum and it’s elements Needs of the patient and the health care system
The future of the specialty
Room: Hall A Chairpersons: Epidemiological data Pathomechanisms
Room: Hall I/K Chairpersons:
Room: Hall M/L Chairpersons: Introductory lecture: Can we get a grip on complexity in allergy research?
Room: Hall N/O Chairpersons: 10.30-12.15
Room: Hall A Chairpersons: Allergology: The birth of a new medical discipline Allergy: A burden for the patient and for society Is the prevalence of allergy continuously increasing? The allergy epidemics: A look into the future 12.15 – 13.30 Hall X & Y Posters 216 - 925 and 1636 - 1689 in the Poster Exhibition are discussed during the lunch hour. All delegates attending the Poster Exhibition will receive a sandwich lunch. 13.30 – 15.15 Room: Hall B Challenging the status quo: expanding treatment
expectations in severe asthma Clinical evidence that anti-IgE treatment improves
outcomes for severe asthma patients Measures of success: evaluating patient benefit
to anti-IgE treatment at 16 weeks Which patients benefit most from anti-IgE treatment?
Room: Hall A Chairpersons: Epidemiology of anaphylaxis Mechanism of anaphylaxis Management of anaphylaxis The Symposium is acknowledged as an educational programme of the
WAO
Room: Hall F Chairpersons: Natural history of rhinitis, rhinosinusitis
and asthma Local IgE production Links between rhinitis and asthma Rhinitis treatment - can it moderate present
and prevent future asthma?
Room: Hall C Chairpersons: Definition and classification Differences between chronic rhinosinusitis
and nasal polyps CRS infection and inflammation Treatment strategies in CRS and NP
Room: Hall G/H Chairpersons: In vitro allergy diagnosis: following the flow Basophil activation tests for allergy diagnosis CD203c for allergy diagnosis Flow cytometry of T cell markers and cytokines
in allergy
Room: Hall E1 Chairpersons: Biology of neurotrophins and neuropeptides Animal models of neural mechanisms Neurotrophins in asthma Neurogenic inflammation in asthma
Room: Hall I/K Chairpersons: Biology of IgE IgE and the high affinity receptor FceRI The IgE-CD23 interaction Membrane IgE
Room: Hall E2 Chairpersons: N- and O-glycans of plant and insect allergens Clinical significance of protein glycans Occurrence of anti-Carbohydrate Determinants
IgE Cross-reactive carbohydrates in insect sting
allergy
Room: Hall D Chaipersons: How to write a paper How to write a paper… and get it published
Room: Hall M/L Chairpersons: Introductory lecture: The allergic immune responses:
where do we stand?
Room: Hall N/O Chairpersons: 15.30 – 17.15 Room: Hall B Chairperson: Welcome and Introduction Understanding Daily Variation in Symptoms
of Upper Respiratory Disease Management of Morning Symptoms Addressing the Impact of Symptoms on Sleep Interactive Case Studies (with Audience Response
System) Question and Answer Session
Room: Hall D Chairperson: Immunological principles of drug hypersensitivity:
many questions, some answers Clinical features, ethiology and pathogenetic
aspects of Stevens-Johnson Syndrome and toxic epidermal necrolysis Clinical features, ethiology and pathogenetic
aspects of drug reaction, eosinophilia and systemic symptoms Prospective evaluation of risk factors of cutaneous
drug reactions in patients with AIDS Room: Hall A Chairpersons: Epidemiology and food allergy (childhood and
adulthood) Diagnosis of food allergy Oral allergy syndrome: cross reactivities Treatment and prognosis of food allergy
Room: Hall F Chairperson: Current understanding of IgE regulation Plasma cell-derived IgE IgE-mediated regulation of T cell activity IgE regulation of effector cells The Allergopharma Award will be presented during this Symposium.
Room: Hall E1 Chairpersons: ADAM33, a protease-encoding gene The DPP10 and PHF11 gene GPRA, a novel G protein-coupled receptor related
to asthma Will these discoveries lead to effective new
therapies?
Room: Hall E2 Chairpersons: Burden of occupational rhinitis Diagnosis of occupational rhinitis Relationship of occupational asthma and rhinitis Outcome and compensation
Room: Hall G Chairperson: Chemoattractants and their receptors in inflammation Chemokine receptors in skin homing PI3K delta in the allergic response Tuning chemokine activity Targeting chemokine receptors in allergy
Room: Hall I/K Chairpersons: Introduction Immunological factors determining outcome after
organ transplantation - lessons from the Collaborative Transplant Study Tolerance induction through gene therapy in
transplant and autoimmunity models Progress towards clinical tolerance induction
Room: Hall M/L Chairpersons: Introductory lecture: Dendritic cells: the
link between innate and adaptive immunity
Room: Hall N/O Chairpersons: 17.30 – 19.15
Room: Hall B Chairperson: Voice of the patient Pharmacology and antihistamines: receptors
and beyond Challenge models and clinical outcomes QoL: the ultimate benefit of treatment
Room: Hall I/K Chairperson: The Hypoallergenic concept: What and why Clinical data with high dose hypoallergenic
preparations Clinical data with hypoallergenic recombinant
SIT Room: Hall G/H Chairpersons: Introduction The role of inflammatory mediators in AR. Anti-inflammatory effects of antihistamines Effects of antihistamines on CNS and cardiovascular
system The role of antihistamines in the treatment
of AR according to ARIA Panel discussion
Room: Hall C Chairpersons: Neuroimmunology Treatment of autoimmune diseases Complement in clinical immunology Immunological control and enhancement of viral
infections:
Room: Hall E1 Chairpersons:
Room: Hall E2 Chairpersons:
Room: Hall M/L Chairpersons: Introductory lecture: The need for animal models
in allergy
Room: Hall N/O Chairperson: |